MODERN TRENDS IN MANAGEMENT OF MOOREN’S ULCER

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 2

Abstract

BACKGROUND Mooren's ulcer is a chronic peripheral corneal ulceration featuring conjunctival immunoglobulin deposits. It is considered as the result of a limbic immune process with hyperactivation of T and B lymphocytes. The exact aetiology remains unknown. The response to topical steroid therapy, immunosuppressants and surgical procedures is usually poor and the visual outcome can be devastating. We report our good results in managing these cases with 3 days of intravenous methylprednisolone and 3-7 months of cyclosporine eyedrops. MATERIALS AND METHODS We treated 27 patients of Mooren’s ulcer with 1 g intravenous methylprednisolone for 3 days along with topical cyclosporine eyedrops for 3-7 months. RESULTS Six patients had Mooren’s ulcer in both eyes. Six patients had Mooren’s ulcer in their one eye. All these 12 cases had poor response to topical steroids and conjunctival peritomy and Mooren’s ulcer was progressing. Three patients had progressing Mooren’s ulcer in their eyes despite lamellar keratoplasty and topical steroids therapy. Twelve patients were freshly diagnosed as Mooren’s ulcer. All these twenty seven cases were treated by giving 3 doses of 1 g intravenous methylprednisolone over 3 days along with topical cyclosporine A (0.05%) eyedrops. They responded very well to the treatment and corneal healing was obtained in 5-7 months of treatment. No adverse effects of above treatment were seen in any case. CONCLUSION We report the effectiveness of 3 doses of 1 g intravenous methylprednisolone given over 3 days along with topical cyclosporine eyedrops in treatment of Mooren’s ulcer. We propose the above regime for treatment of Mooren’s ulcer. The benefit is most likely due to temporary switching off the immunodamaging process by short course of high-dose methylprednisolone followed by immunosuppression by cyclosporine A.

Authors and Affiliations

Vinod Kumar Baranwal, ajendra Prasad Gupta, Satyabala K, Shikhar Gaur

Keywords

Related Articles

PIGMENTED BASAL CELL CARCINOMA: A RARE CLINICAL AND HISTOPATHOLOGICAL VARIANT

Basal cell carcinoma is a common malignant tumour of skin, commonly referred to as „rodent ulcer‟. It is common in the head and neck region. Exposure to ultraviolet radiation is an important risk factor. Pigmented basal...

CONGENITAL MATURE CYSTIC TERATOMA OF PAROTID: A RARE CASE

INTRODUCTION We reported congenital mature cystic teratoma of parotid that presented as a swelling in the left parotid gland region since birth, increasing in size gradually. Teratoma is common neoplasm, but is very rare...

A CASE REPORT OF CUSHING’S SYNDROME INDUCED HYPERCOAGULABLE STATE

PRESENTATION OF CASE A 25-year-old female patient presented with complaints of swelling of the left lower limb associated with pain in the left leg for 15 days duration. Patient had history of weight gain and irregular m...

QUALITY OF LIFE MEASUREMENT IN PATIENTS WITH PSORIASIS AT A TERTIARY CARE TEACHING HOSPITAL OF SURAT, GUJARAT

BACKGROUND Psoriasis is a chronic, inflammatory dermatosis characterized by erythematous, scaly lesions covering extensive areas of the skin with prevalence of 2-3% in the general population. Psoriasis do not affect surv...

PSEUDODOUBLING OF OPTIC DISC WITH BILATERAL SERPIGINOUS CHOROIDITIS AND MACULAR CHOROIDAL NEOVASCULARISATION- A CASE REPORT

PRESENTATION OF CASE We present here a case of pseudodoubling of the optic diska spectacular and rare clinical presentation. Of additional interest is that this case also includes another rare presentation, which is serp...

Download PDF file
  • EP ID EP448620
  • DOI 10.18410/jebmh/2018/34
  • Views 82
  • Downloads 0

How To Cite

Vinod Kumar Baranwal, ajendra Prasad Gupta, Satyabala K, Shikhar Gaur (2018). MODERN TRENDS IN MANAGEMENT OF MOOREN’S ULCER. Journal of Evidence Based Medicine and Healthcare, 5(2), 155-158. https://europub.co.uk/articles/-A-448620